KMG Chemicals Inc. (NYSE:KMG) will be issuing its Q416 quarterly earnings data on Thursday, October 13th. Analysts expect the company to announce earnings of $0.40 per share and revenue of $77.10 million for the quarter.
KMG Chemicals Inc. (NYSE:KMG) opened at 28.11 on Tuesday. The firm has a 50 day moving average of $27.89 and a 200-day moving average of $25.52. KMG Chemicals Inc. has a 52-week low of $18.87 and a 52-week high of $29.45. The stock has a market cap of $329.87 million, a PE ratio of 18.36 and a beta of 0.67.
The company also recently disclosed a quarterly dividend, which will be paid on Tuesday, October 18th. Stockholders of record on Tuesday, October 11th will be paid a $0.03 dividend. The ex-dividend date is Thursday, October 6th. This represents a $0.12 dividend on an annualized basis and a dividend yield of 0.43%. KMG Chemicals’s dividend payout ratio (DPR) is presently 7.84%.
Several institutional investors have recently modified their holdings of KMG. Panagora Asset Management Inc. raised its position in shares of KMG Chemicals by 804.0% in the second quarter. Panagora Asset Management Inc. now owns 14,853 shares of the company’s stock worth $386,000 after buying an additional 13,210 shares in the last quarter. A.R.T. Advisors LLC bought a new position in shares of KMG Chemicals during the second quarter worth $202,000. Menta Capital LLC raised its position in shares of KMG Chemicals by 19.7% in the second quarter. Menta Capital LLC now owns 30,273 shares of the company’s stock worth $787,000 after buying an additional 4,982 shares in the last quarter. Rhumbline Advisers raised its position in shares of KMG Chemicals by 3.2% in the second quarter. Rhumbline Advisers now owns 12,744 shares of the company’s stock worth $331,000 after buying an additional 392 shares in the last quarter. Finally, TFS Capital LLC bought a new position in shares of KMG Chemicals during the second quarter worth $1,495,000. Hedge funds and other institutional investors own 68.91% of the company’s stock.
Separately, Zacks Investment Research raised shares of KMG Chemicals from a “hold” rating to a “buy” rating and set a $30.00 price objective for the company in a research note on Monday, June 13th.
KMG Chemicals Company Profile
KMG Chemicals, Inc manufactures, formulates and globally distributes specialty chemicals. The Company operates businesses selling electronic chemicals, industrial wood treating chemicals and industrial valve lubricants and sealants. The Company operates through two segments: Electronic chemicals and Other chemicals.
Receive News & Ratings for KMG Chemicals Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for KMG Chemicals Inc. and related companies with MarketBeat.com's FREE daily email newsletter.